IL-8 is a pleiotropic chemokine with a dual function, which acts as a chemoattractant for neutrophils, inducing innate immune responses, whereas in the ovarian cancer environment, it contributes to the pro-survival activity of tumor cells and resistance to chemotherapy. Here, CXCL8 is linked to ovarian carcinoma.